日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Osteopontin is a therapeutic target that drives breast cancer recurrence

骨桥蛋白是驱动乳腺癌复发的治疗靶点。

Yu Gu ,Tarek Taifour ,Tung Bui ,Dongmei Zuo ,Alain Pacis ,Alexandre Poirier ,Sherif Attalla ,Anne-Marie Fortier ,Virginie Sanguin-Gendreau ,Tien-Chi Pan ,Vasilios Papavasiliou ,Nancy U Lin ,Melissa E Hughes ,Kalie Smith ,Morag Park ,Michel L Tremblay ,Lewis A Chodosh ,Rinath Jeselsohn ,William J Muller

Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer

纯雌激素受体拮抗剂增强卡培他滨在 ESR1 突变乳腺癌中的活性

Albert Grinshpun #, Douglas Russo #, Wen Ma #, Ana Verma, Francisco Hermida-Prado, Shira Sherman, Giorgio Gaglia, Sheheryar Kabraji, Gregory Kirkner, Melissa E Hughes, Nancy U Lin, Zachary Sandusky, Agostina Nardone, Cristina Guarducci, Quang-De Nguyen, Sandro Santagata, Zsuzsanna Nagy, Rinath Jesel

Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer

多重组织成像检测方法的验证及乳腺癌中HER2异质性新模式的检测

Jennifer L Guerriero #   ,Jia-Ren Lin # ,Ricardo G Pastorello ,Ziming Du ,Yu-An Chen,Madeline G Townsend ,Kenichi Shimada   ,Melissa E Hughes,Siyang Ren,Nabihah Tayob,Kelly Zheng,Shaolin Mei,Alyssa Patterson,Krishan L Taneja,Otto Metzger,Sara M Tolaney,Nancy U Lin,Deborah A Dillon,Stuart J Schnitt,Peter K Sorger ,Elizabeth A Mittendorf   ,Sandro Santagata

STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer

STING激动剂可重编程肿瘤相关巨噬细胞,并克服BRCA1缺陷型乳腺癌模型中对PARP抑制剂的耐药性。

Qiwei Wang # ,Johann S Bergholz # ,Liya Ding ,Ziying Lin ,Sheheryar K Kabraji ,Melissa E Hughes ,Xiadi He ,Shaozhen Xie ,Tao Jiang ,Weihua Wang ,Jason J Zoeller ,Hye-Jung Kim ,Thomas M Roberts ,Panagiotis A Konstantinopoulos ,Ursula A Matulonis ,Deborah A Dillon ,Eric P Winer ,Nancy U Lin ,Jean J Zhao

p16INK4A-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases

p16INK4A 缺陷可预测 HER2+ 乳腺癌脑转移对 HER2 和 CDK4/6 联合抑制的反应

Jing Ni #, Sheheryar Kabraji #, Shaozhen Xie, Yanzhi Wang, Peichen Pan, Xiaofang He, Zongming Liu, Jose Palbo Leone, Henry W Long, Myles A Brown, Eric P Winer, Deborah A R Dillon, Nancy U Lin, Jean J Zhao

Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium

脑肿瘤中的固体应激会导致神经元丢失和神经功能障碍,可以通过锂来逆转

Giorgio Seano, Hadi T Nia, Kyrre E Emblem, Meenal Datta, Jun Ren, Shanmugarajan Krishnan, Jonas Kloepper, Marco C Pinho, William W Ho, Mitrajit Ghosh, Vasileios Askoxylakis, Gino B Ferraro, Lars Riedemann, Elizabeth R Gerstner, Tracy T Batchelor, Patrick Y Wen, Nancy U Lin, Alan J Grodzinsky, Dai Fu

Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer

选择性 JAK1/2 抑制剂鲁索替尼治疗转移性三阴性乳腺癌的 II 期研究

Daniel G Stover #, Carlos R Gil Del Alcazar #, Jane Brock, Hao Guo, Beth Overmoyer, Justin Balko, Qiong Xu, Aditya Bardia, Sara M Tolaney, Rebecca Gelman, Maxwell Lloyd, Yu Wang, Yaomin Xu, Franziska Michor, Vivian Wang, Eric P Winer, Kornelia Polyak, Nancy U Lin